Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ERTAPENEM FOR INJECTION DIN 02492148

Status: Marketed
Holder: AURO PHARMA INC
Molecule: ERTAPENEM (ERTAPENEM SODIUM)
Available to quote

Health Canada record

Active ingredient(s)ERTAPENEM (ERTAPENEM SODIUM) 1 G
Dosage formPowder For Solution
RouteIntramuscular; Intravenous
SchedulePRESCRIPTION
ClassHuman
ATCJ01DH03 ERTAPENEM
Original market date08-Oct-2021
Current status date08-Oct-2021
SourceHealth Canada DPD

Establishment licence of the holder

Auro Pharma Inc — licence 101305, currently licensed, last inspection rating C (2023-09-27).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ERTAPENEM (ERTAPENEM SODIUM)

DINProductCompanyFormStrengthStatus
02537176ERTAPENEM FOR INJECTIONEUGIA PHARMA INC.Powder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GMarketed
02490773ERTAPENEM FOR INJECTIONJUNO PHARMA CANADA INC.Powder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GMarketed
02496127ERTAPENEM FOR INJECTIONFRESENIUS KABI CANADA LTDPowder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GMarketed
02505126ERTAPENEM FOR INJECTIONHIKMA CANADA LIMITEDPowder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GApproved
02511150ERTAPENEM FOR INJECTIONDR REDDY'S LABORATORIES LTDPowder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GMarketed
02247437INVANZMERCK CANADA INCPowder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GMarketed
02539500ERTAPENEM FOR INJECTIONOMEGA LABORATORIES LIMITEDPowder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GCancelled Pre Market
02539799ERTAPENEM FOR INJECTIONMANTRA PHARMA INCPowder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
226292019-09-11Abbreviated New Drug Submission (ANDS)
Request a quote for ERTAPENEM FOR INJECTION

How to read a Canadian DIN record